The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer
PID: 15325619
Pawlik TM, Bucholz TA, Kuerer HM. The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg. 2004;199:479-92.
Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003–2010: a report from the national cancer data base
PID: 23975298
Czechura T, Winchester DJ, Pesce C, Huo D, Winchester DP, Yao K. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the national cancer data base. Ann Surg Oncol. 2013;20(10):3223-32.
Association between treatment with brachytherapy versus whole-breast irradiation and subsequent mastectomy, complications and survival among older women with invasive breast cancer
Smith GL, Xu Y, Buchholz TA, et al. Association between treatment with brachytherapy versus whole-breast irradiation and subsequent mastectomy, complications and survival among older women with invasive breast cancer. JAMA. 2012;307:1827-37.
Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial breast irradiation: the William Beaumont hospital experience
PID: 17467920
Chao KK, Vicini FA, Wallace M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial breast irradiation: the William Beaumont hospital experience. Int J Radiat Oncol Biol Phys. 2007:69:32-40.
NSABP Protocol B-39/RTOG Protocol 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Accessed 1 Feb 2014
Radiation Therapy Oncology Group. NSABP Protocol B-39/RTOG Protocol 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Available from: www.rpc.mdanderson.org/rpc/credentialing/files/B39_Protocol1.pdf. Accessed 1 Feb 2014.
Patterns of use and short-term complications of breast brachytherapy in the national Medicare population from 2008–2009
PID: 23091103
Presley CJ, Soulos PR, Herrin J, et al. Patterns of use and short-term complications of breast brachytherapy in the national Medicare population from 2008-2009. J Clin Oncol. 2012;30:4302-07.
Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
Khan AJ, Arthur D, Vicini F, et al. Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2012;19:1477-1483.
A single-institution review of accelerated partial breast irradiation in patients considered “cautionary” by the American Society for Radiation Oncology
PID: 21769461
Stull TS, Goodwin MC, Gracely EJ, Chernick MR, Carella RJ, Frazier TG, et al. A single-institution review of accelerated partial breast irradiation in patients considered “cautionary” by the American Society for Radiation Oncology. Ann Surg Oncol. 2012;19:553-559.
Increased rates of long-term complications after Mammosite brachytherapy compared with whole breast radiation therapy
PID: 23830216
Rosenkranz KM, Tsui E, McCabe EB, et al. Increased rates of long-term complications after mammosite brachytherapy compared with whole breast radiation therapy. J Am Coll Surg. 2013;217:497-502.
Breast conserving therapy with accelerated partial breast versus external beam whole breast irradiation: comparison of imaging sequel and complication in a matched population
Monticciolo DL, Biggs K, Gist AK, et al. Breast conserving therapy with accelerated partial breast versus external beam whole breast irradiation: comparison of imaging sequel and complication in a matched population. Breast J. 2001:17:187-190.
Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors
PID: 16545918
Evans SB, Kaufman SA, Price LL, Cardarelli G, Dipetrillo TA, Wazer DE. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors. Int J Radiat Oncol Biol Phys. 2006:65:333-339.
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy
PID: 18778970
Watkins JM, Harper JL, Dragun AE, et al. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008:7(4):305-309.
Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. Am Surg. 2000:66(5):444-450.
